These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 13899397

  • 1. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
    GODDARD ES.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():87-90. PubMed ID: 13899397
    [No Abstract] [Full Text] [Related]

  • 2. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
    LESSE S.
    Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined tranylcypromine-trifluoperazine therapy in obstetrics and gynaecology.
    PRUETER GW.
    Can Psychiatr Assoc J; 1962 Apr; 7(Suppl)():77-83. PubMed ID: 14489022
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined tranlcypromine and trifluoperazine therapy in general medicine.
    LEWIS RA.
    Can Psychiatr Assoc J; 1962 Apr; 7(Suppl)():74-6. PubMed ID: 14464901
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tranylcypromine and trifluoperazine in the management of the menopausal syndrome.
    MAZZA PA.
    Dis Nerv Syst; 1962 Apr; 23():224-5. PubMed ID: 14471846
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Some effects of tranylcypromine and trifluoperazine on electrocortical activity (EEG activation).
    LING GM.
    Can Psychiatr Assoc J; 1962 Apr; 7(Suppl)():44-54. PubMed ID: 14465574
    [No Abstract] [Full Text] [Related]

  • 11. The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin).
    SCHIELE BC.
    Am J Psychiatry; 1960 Sep; 117():245-6. PubMed ID: 13747600
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tranylcypromine-trifluoperazine in the management of emotional distress.
    BAUM ES.
    Int Rec Med; 1961 May; 174():303-6. PubMed ID: 13687959
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prediction of response to tranylcypromine plus trifluoperazine by the MMPI.
    SULZER ES, SCHIELE BC.
    Am J Psychiatry; 1962 Jul; 119():69-70. PubMed ID: 13918361
    [No Abstract] [Full Text] [Related]

  • 19. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F.
    Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.